Novel Cdk2/Cdk9 Inhibitor Fadraciclib Targets Cell Survival and Dna Damage Pathways and Synergizes with Encorafenib in Human Colorectal Cancer Cells with Braf(V600E)
AuthID
P-019-V60
P-019-V60
© 2026 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service